VictoryShares US EQ Income Enhanced Volatility Wtd ETF (NASDAQ: CDC)

Latest news for VictoryShares US EQ Income Enhanced Volatility Wtd ETF (NASDAQ:CDC)

VictoryShares US EQ Income Enhanced Volatility Wtd ETF

Utilities

Financial Services

Consumer Defensive

Energy

Healthcare

Technology

Consumer Cyclical

Communication Services

Industrials

Basic Materials

The fund seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its assets directly or indirectly in the securities included in the Nasdaq Victory US Large Cap 100 High Dividend Long/Cash Volatility Weighted Index. The index identifies the 100 highest dividend yielding stocks in the Nasdaq Victory US Large Cap 500 Volatility Weighted Index.

The Coca-Cola Company

Philip Morris International Inc.

Kimberly-Clark Corp.

Lockheed Martin

Southern Co.

Duke Energy Corp.

Kinder Morgan Inc./de

Kellogg Co.

Williams Cos. Inc.

Pepsico Inc.

3-28-12 Daily Small Cap Market News and Stock Highlights from SmallCapVoice

PositiveID Corporation Receives Nucleic Acids From the CDC Influenza Division to Develop a Diagnostic Assay to Detect H5N1 Avian Flu

Topics

General

3 New Devices That Are Revolutionizing Diabetes Management

Goldcrest Co Ltd

Snacks giant Mondelez International&nbsp;Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDLZ#NASDAQ">MDLZ</a>) shares are trading lower in <a target="_blank" href="https://www.benzinga.com/premarket" rel="noreferrer noopener">premarket on Wednesday</a>.
The company reported fourth-quarter sales growth of 3.1% year-on-year to $9.60 billion, missing the analyst <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/g43478380/mondel-z-international-reports-q4-and-fy-2024-results" rel="noreferrer noopener">consensus estimate of $9.64 billion</a>.
Adjusted EPS of $0.65 also <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">missed the consensus estimate of $0.66.</a>
Revenues in Asia, Middle East&nbsp;&amp; Africa surged 9.9% whereas Latin America plunged 7.2%. Revenue from Europe and North America increased 5.8% and 0.1% respectively.
Gross profit for the quarter climbed 6.9% to $3.71 billion and the gross margin expanded 130 basis points to 38.6%.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/earnings/25/02/43462736/cosmetics-major-estee-lauder-q2-earnings-sales-slump-restructuring-deepens-but-ceo-bets-on-beauty-reimagined" rel="noreferrer noopener">Cosmetics Major Estee Lauder Q2 Earnings: Sales Slump, Restructuring Deepens, But CEO Bets On &#8216;Beauty Reimagined&#8217;</a>
Operating income jumped 35% to $1.61 billion and the operating margin expanded 400 basis points to 16.8%.
The operating cash flow for the twelve months totaled $4.9 billion, with a free cash flow of $3.5 billion.
&#8220;As we transition into 2025, we remain focused on executing against our long-term growth strategy and delivering on our chocolate business playbook to navigate unprecedented cocoa cost inflation,&#8221; said Chair and CEO Dirk Van de Put.
Outlook: Mondelez expects FY25 organic net revenue growth <a href="https://www.benzinga.com/calendars/guidance">to be approximately 5%.</a>
The company expects adjusted EPS to decline approximately 10% on a constant currency basis due to unprecedented cocoa cost inflation.
Mondelez sees FY25 free cash flow of over $3 billion.&nbsp;The company estimates currency translation would decrease full-year net revenue growth by approximately&nbsp;2.5%&nbsp;and negatively impact Adjusted EPS by $0.12.
Price Action: MDLZ shares are trading lower by 4.44% at $53.63 in premarket at the last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43463646/alcohol-giant-diageo-suspends-guidance-as-trumps-tariff-looms" target="_blank" rel="noreferrer noopener">Alcohol Giant Diageo Suspends Medium-Term Guidance As Trump&#8217;s Tariff Looms</a></li>
</ul>
Image via Shutterstock.

Earnings

Equities

News

Guidance

Movers

Trading Ideas

MDLZ

Snacks Giant Mondelez Q4 Earnings: Sales Miss, EPS Falls Short, Cocoa Inflation Threatens 2025 & More

Needham analyst Matt Dezort reiterates Varonis Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRNS#NASDAQ">VRNS</a>) with a Buy and maintains $67 price target.

Price Target

Reiteration

Analyst Ratings

VRNS

Needham Reiterates Buy on Varonis Systems, Maintains $67 Price Target

Macro Economic Events

Econ #s

Economics

U.K. Services Purchasing Managers Index For January 50.8 Vs. 51.2 Est.; 51.1 Prior

Baird analyst Peter Arment upgrades Mercury Sys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRCY#NASDAQ">MRCY</a>) from Neutral to Outperform and raises the price target from $37 to $58.

Upgrades

MRCY

Baird Upgrades Mercury Sys to Outperform, Raises Price Target to $58

U.K. Composite Purchasing Managers' Index For January 50.6 Vs. 50.9 Est.; 50.4 Prior

Toyota Motor Reported Q3 Toyota and Lexus Vehicle Sales Of 2.73M

Toyota Motor Expects FY25 Revenue Of $309.21B Vs $291.4B Est And EPS Of $29.74 Vs $19.84 Est

PepsiCo Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEP#NASDAQ">PEP</a>) reported a <a href="https://www.benzinga.com/25/02/43460249/pepsicos-q4-sales-miss-estimates-on-downcast-performance-in-north-america-stock-dives">mixed fourth quarter</a>, missing revenue while beating earnings per share estimates. The management highlighted key strategic changes to its snack business Frito-Lay North America, which manufactures popular products like Lays, Cheetos, and Doritos.
What Happened: Frito-Lay North America (FLNA) experienced a decline in organic revenue for both the full year 2024 and the fourth quarter. Full-year organic revenue decreased by 0.5%, a significant drop from the 9% growth seen in 2023. In the fourth quarter alone, organic revenue was down 2%.
PepsiCo reinvested heavily in FLNA in Q4, funded partly by one-time gains, to revitalize volume growth. This included tactical spending and strategic groundwork for 2025.
The chairman and CEO of the company, Ramon Luis Laguarta in response to an analyst during its earnings call said, &#8220;We reinvested most of the one-time gains in building the infrastructure to capture those opportunities in 25.&#8221;
The management also highlighted that FLNA is emphasizing value offerings at different price points and pack sizes. This is alongside healthier options like products with lower sodium, and fat, better ingredients, and plant-based items. The management is addressing consumer preferences for &#8220;positive choices&#8221; and &#8220;permissible offerings.&#8221;
PepsiCo Beverages North America organic revenue increased 1% in 2024, which compares to 7% organic revenue growth in the prior year, whereas, Quaker Foods North America organic revenue declined 14 percent in 2024.
See Also: <a href="https://www.benzinga.com/general/market-summary/25/02/43487630/trump-media-or-trump-coin-where-have-investors-lost-more-money-since-the-47th-president-entered-the-white-house">Trump Media or Trump Coin: Where Have Investors Lost More Money Since the 47th President Entered the White House?</a>
Why It Matters: Laguarta said, &#8220;I think there&#8217;s a higher level of awareness in general of American consumers toward health and wellness, driven by conversations around obesity drugs, and other health-related topics. This increased awareness is influencing consumer behavior, which PepsiCo is addressing through its strategies&#8221;.
Fourth-quarter sales fell slightly short of expectations, decreasing 0.2% year-over-year to $27.78 billion compared to the projected $27.89 billion. However, adjusted EPS of $1.96 beat the $1.94 consensus.
For the next full year, PepsiCo projects low single-digit organic sales growth for 2025, anticipating a gradual improvement in North America. They reaffirmed their long-term targets of 4-6% organic sales growth and high single-digit EPS growth.
Restructuring efforts aim to boost international growth and North American efficiency, the management highlighted. PepsiCo also said that it is mindful of macroeconomic uncertainties and evolving consumer behavior, including the potential impact of weight loss drugs, though no direct impact has been observed.
Price Action: Shares of PepsiCo fell 4.51% to end Tuesday at $143.49 apiece. It rose by 0.49% in after-hours. The exchange-traded fund tracking the S&amp;P 500 index, SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) rose 0.67% to $601.78 on Tuesday.
The average price target among 20 analysts <a href="https://www.benzinga.com/quote/PEP/analyst-ratings">tracked by Benzinga</a> is $178.35 with a ‘hold' rating. The estimates range from $155 to $200 apiece. Recent ratings from RBC Capital, JP Morgan, and Deutsche Bank suggest a $171.67 target, implying a potential upside of 19.05%.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/quote/PEP/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="383" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/05034243/PepsiCo-ANR-1024x383.png" alt="" class="wp-image-766528" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/05034243/PepsiCo-ANR-1024x383.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/05034243/PepsiCo-ANR-300x112.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/05034243/PepsiCo-ANR-768x287.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/05034243/PepsiCo-ANR.png 1068w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/technicals/25/02/43459342/chip-equipment-maker-applied-materials-stock-is-up-over-9-ytd-even-as-charts-point-to-bearish-patterns-heres-what-investors-should-look-at">Chip Equipment Maker Applied Materials Stock Is Up Over 9% YTD Even As Charts Point To Bearish Patterns: Here&#8217;s What Investors Should Look At</a></li>
</ul>
Photo courtesy: Shutterstock

Markets

PepsiCo Revamps Lays, Cheetos, And Doritos Maker Frito Lay As North American Sales Take A Hit, Shifts Focus To Health-Conscious Customers

Earnings Beats

Toyota Motor Q3 2025 GAAP EPS $14.34 Up From $6.81 YoY, Sales $80.988B Beat $73.981B Estimate

CANG

Cango Announced Number Of Bitcoins Produced Stood At 538.2 In January 2025

Morgan Stanley&#8217;s CIO&nbsp;cautioned investors regarding the risks of President, Donald Trump&#8216;s growth-negative policies such as <a href="https://www.benzinga.com/economics/macro-economic-events/25/02/43454424/china-strikes-back-new-tariffs-up-to-15-on-certain-us-imports-in-retaliation-for-trumps-10-levy-on-chinese-goods">tariffs </a>and immigration enforcement. 
What Happened: The Chief U.S. Equity Strategist and CIO of&nbsp;Morgan Stanley, Mike Wilson, predicted weak stock returns for the S&amp;P 500 in&nbsp;the next 3 to 6&nbsp;months.
He pointed out that the &#8220;equity negative&#8221; policies were introduced before the &#8220;equity positive&#8221; measures had sufficient time to take effect in the form of less crowding out and lower interest rates. He mentioned deregulation, tax extensions, and reduced government spending as some of these &#8216;equity-positive&#8217; measures.
He cautioned about tough times ahead and predicted the S&amp;P 500 to trade between $5,500-$6,100 in&nbsp;the next 3 to 6&nbsp;months, with a fourth-quarter price target of $6,500. &#8220;Since we have been expecting tariffs to be implemented, this realization only furthers our preference for consumer services over goods. It also supports our preference for financials and other domestically geared businesses that have limited currency or trade exposures,&#8221; added the Morgan Stanley CIO.
The Morgan Stanley top strategist believes that DeepSeek&#8217;s latest AI model has added another level of uncertainty for investors and reiterated his preference for software and media over semiconductors. However, BofA&#8217;s Vivek Arya stated <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/02/43474406/nvidia-still-a-top-pick-as-microsoft-meta-stick-with-gpus-despite-deepseek-challenge-analyst">yesterday </a>&#8220;Despite DeepSeek&#8217;s supposed ‘revolutionary' optimizations, there is no change thus far to spending intentions at Nvidia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) large customers including Microsoft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) and Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>).&#8221;
SEE ALSO: <a href="https://www.benzinga.com/25/02/43426111/openai-rethinks-open-source-as-deepseek-gains-ground-sam-altman-hints-at-major-changes-in-ai-model-development">DeepSeek Impact Makes OpenAI Rethink Open Source — Sam Altman Hints At Major Changes In Model Development</a>
Why It Matters: In the last two weeks since President Trump&#8217;s inauguration, the market has been nearly flat, with the S&amp;P 500 slipping 0.18% since Jan. 20. Trump&#8217;s announcement of a 25% <a href="https://www.benzinga.com/markets/cannabis/25/02/43476012/trumps-canada-tariffs-bffs-for-decades-what-went-wrong-can-it-really-be-about-fentanyl-unlikely">tariff on imports from Canada and Mexico</a>, which has been postponed by a month. 
Prior to that, the announcement of <a href="https://www.benzinga.com/startups/25/02/43476917/deepseek-a-trojan-horse-kevin-oleary-calls-bs-on-deepseeks-6m-budget-claims-they-ripped-off-60k-nvidia-chips-from-the-black-market">DeepSeek unsettled the technology sector</a>, triggering a brief market selloff.
In addition to Morgan Stanley, economists at Goldman Sachs have raised concerns about the imposition of tariffs. They estimate that for every 5-percentage-point increase in the tariff rate, the S&amp;P 500&#8217;s earnings per share could decline by approximately 1% to 2%.
<ul>
<li>READ MORE: <a href="https://in.benzinga.com/25/02/43439462/us-manufacturing-confidence-tops-forecasts">US Manufacturing Confidence Tops Forecasts, Yet Price Pressures Intensify, &#8216;Could Become A Concern,&#8217; Economist Says</a></li>
</ul>
Image Via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

MSFT

NVDA

Expect Weak Stock Returns For Next 3 Months, Cautions Top Analyst Amid Trump's Trade And Immigration Policies

GXO Logistics Announced That It Has Expanded Its Partnership With Castore, The Performance Sportswear Brand, To Operate Warehousing And Transportation In The UK, US And Europe

Aurora Mobile Announced That Its Leading Enterprise Ai Agent Platform,  GPTBots.ai Has Integrated Deepseek's Janus-pro Into Its Ecosystem As An Open Tool, Further Expanding Its Comprehensive Suite Of Ai Capabilities

On Tuesday, Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) CEO Sundar Pichai hinted at potential future monetization strategies for Gemini AI, including the introduction of ads.
What Happened: During the company's <a href="https://in.benzinga.com/25/02/43479274/alphabet-q4-earnings-highlights-ai-cloud-youtube-momentum-continues-capex-guidance-sends-shares-lower">fourth-quarter earnings</a> call, analyst Ken Gawrelski asked about the long-term monetization strategy for Gemini, particularly whether ads would be integrated into the platform.
In response, Pichai confirmed that while the company is currently focused on free and premium subscription tiers, advertising will likely play a role in the future.
See Also:&nbsp;<a href="https://www.benzinga.com/news/legal/25/01/43325503/mark-zuckerbergs-meta-pays-trump-25-million-to-settle-lawsuit-over-facebook-instagram-ban-after-jan-6-riot-a-big-year-for-redefining-our-relationships-with-governments" target="_blank" rel="noreferrer noopener">Mark Zuckerberg's Meta Pays Trump $25 Million To Settle Lawsuit Over Facebook, Instagram Ban After Jan. 6 Riot: ‘A Big Year For Redefining Our Relationships With Governments'</a>
&#8220;We do have very good ideas for native ad concepts, but you will see us lead with the user experience,&#8221; Pichai stated, adding, &#8220;But I do think we&#8217;re always committed to making the products work and reach billions of users at scale. And advertising has been a great aspect of that strategy.&#8221;
Comparing Gemini's potential ad model to YouTube's approach, he suggested that Google will offer users choices over time. &#8220;Just like you&#8217;ve seen with YouTube, we&#8217;ll give people options over time,&#8221; Pichai added.
For now, however, Google remains focused on driving adoption through subscriptions, he said.
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
Why It Matters: During the earnings call, Pichai also highlighted Google&#8217;s extensive user base, stating that seven of the company&#8217;s products and platforms, each with over two billion users, are now integrating Gemini.
He also underscored Google&#8217;s leadership in AI, noting that its generative media models and Gemini consistently rank at the top of industry leaderboards and benchmarks. In fact, more than 4.4 million developers are currently using Gemini models— double the number from six months ago.
Alphabet reported fourth-quarter revenue of $96.5 billion, a 12% year-over-year increase. However, it fell short of the Street consensus estimate of $96.6 billion, according to <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent020425&amp;t=be2bearmibe3na1">Benzinga Pro</a>.
Price Action: As of early Wednesday, Alphabet's Class A shares were down 7.35% in pre-market trading, while Class C shares had fallen 7.08%. On Tuesday, Class A shares closed 2.56% higher at $206.38, while Class C shares rose 2.50% to $207.71.
Check out more of Benzinga's Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43487551/sundar-pichai-acknowledges-deepseeks-ai-advancementsbut-says-googles-gemini-still-leads-in-cost-performance-and-l">Sundar Pichai Downplays DeepSeek Threat — Google&#8217;s Gemini Still Leads In Cost, Performance, And Latency</a></li>
</ul>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.
Photo courtesy: Google

Tech

GOOG

GOOGL

Google's Gemini AI Could Soon Include Ads — Sundar Pichai Hints At Future Monetization Beyond Subscriptions

Trump Media &amp; Technology Group Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>) had thin trading volumes on Tuesday as its valuations have skyrocketed and its stock has fallen since the reelection of President Donald Trump, the recent charts point towards a weakness in the stock.
What Happened: DJT&#8217;s trading volume was significantly lower than average as of Tuesday&#8217;s close. Only 3.53 million shares were traded compared to the average of 20.03 million.
The technical analysis of its simple daily moving averages signals a downtrend with mixed momentum indicators.
DJT shares closed Tuesday at $30.62, lower than its 200-day simple moving average of $32.56, and 50-day average at $34.47. It was also lower than its eight-day average of $31.16 and the 20-day average of $34.87. This indicates a bearish downtrend.
However, the momentum indicators were mixed. The relative strength index of 40.59 showed that the stock is in the neutral zone. whereas the negative MACD (moving average convergence/divergence) indicator of 1.27 suggests potential for downward momentum in the near term.
<figure class="wp-block-image size-large"><a href="https://pro.benzinga.com/dashboard"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/05025129/DJT-tech-chart-1024x576.png" alt="" class="wp-image-766407" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/05025129/DJT-tech-chart-1024x576.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/05025129/DJT-tech-chart-300x169.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/05025129/DJT-tech-chart-768x432.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/05025129/DJT-tech-chart-1536x864.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/05025129/DJT-tech-chart.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
According to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>, the company has a price-to-sales ratio of 1,013, signaling the company is overvalued. The price-to-earnings ratio cannot be used as the metric to compute valuation as the company had an operating loss of $23.7 million and a net loss of $19.2 million, in the third quarter.
See Also: <a href="https://www.benzinga.com/25/02/43425958/late-trump-memecoin-sale-costs-trader-33-million-in-potential-gains">TRUMP Memecoin Sale Cost Trader $33 Million In Potential Gains As Memecoin Plunges 76% From Market Top</a>
Why It Matters: Trump held 57% of the company, however, in December he <a href="https://www.benzinga.com/markets/equities/24/12/42609228/trump-transfers-entire-djt-stake-to-revocable-trust-ahead-of-inauguration">transferred</a> his entire stake of 114,750,000 shares to Donald J. Trump Revocable Trust of which he is the sole beneficiary. The DJT stock, which soared after Trump won the election, has declined 9.78% since Nov. 5.
<figure class="wp-block-image size-large"><a href="https://pro.benzinga.com/dashboard"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/05025237/DJT-since-elections-1-1024x576.png" alt="" class="wp-image-766409" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/05025237/DJT-since-elections-1-1024x576.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/05025237/DJT-since-elections-1-300x169.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/05025237/DJT-since-elections-1-768x432.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/05025237/DJT-since-elections-1-1536x864.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/05025237/DJT-since-elections-1.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Additionally, Trump Media is expanding its footprint in the <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43312600/trump-media-group-to-invest-in-bitcoin-financial-services">financial services</a> sector with the launch of Truth.Fi, which is a fintech division aimed at creating investment opportunities with a focus on cryptocurrency.
The company's board has approved a financial strategy that involves investing up to $250 million of its $700 million cash reserves in a range of financial instruments, including tailored exchange-traded funds (ETFs), separately managed accounts (SMAs), and Bitcoin.
CEO Devin Nunes is positioning Truth.Fi as the financial arm of its media network, which already includes Truth Social and the streaming platform Truth+.
The company plans to develop investment products focused on American-first industries, targeting growth sectors such as manufacturing, energy, and crypto/blockchain assets.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/technicals/25/02/43459342/chip-equipment-maker-applied-materials-stock-is-up-over-9-ytd-even-as-charts-point-to-bearish-patterns-heres-what-investors-should-look-at">Chip Equipment Maker Applied Materials Stock Is Up Over 9% YTD Even As Charts Point To Bearish Patterns: Here&#8217;s What Investors Should Look At</a></li>
</ul>
Photo courtesy: Shutterstock

Market Summary

Technicals

BIDU

PINS

RDDT

SNAP

Trump Media & Technology Trading Volume Falls Amid Expensive Valuations And Bearish Charts: Here's What Technical Analysis For DJT Stock Shows

Advanced Micro Devices Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) announced plans to combine its client and gaming segments into a single reportable segment, following a <a href="https://www.benzinga.com/news/earnings/25/02/43480688/amd-q4-earnings-revenue-beat-eps-beat-data-center-continued-growth">steep 59% year-over-year decline</a> in gaming revenue to $563 million in the fourth quarter of 2024.
What Happened: The semiconductor giant will implement the restructuring beginning with its first quarter 2025 financial statements. 
&#8220;We plan to combine the client and the gaming segment into one single reportable segment to align with how we manage the business. Therefore, reporting three segments: data center, client with gaming, and the embedded,&#8221; Chief Financial Officer Jean Hu said, during the company&#8217;s fourth-quarter earnings call. 
The gaming segment&#8217;s sharp decline was primarily attributed to lower semi-custom chip sales as key customers Microsoft and Sony focused on reducing channel inventory. However, AMD noted a significant milestone with cumulative gaming console shipments surpassing 100 million units in the fourth quarter.
&#8220;Looking forward, we believe channel inventories have now normalized and semi-custom sales will return to more historical patterns in 2025,&#8221; said Lisa Su, AMD&#8217;s Chair and CEO, during the earnings call.
See Also: <a href="https://www.benzinga.com/general/market-summary/25/02/43487630/trump-media-or-trump-coin-where-have-investors-lost-more-money-since-the-47th-president-entered-the-white-house">Trump Media Or Trump Coin: Where Have Investors Lost More Money Since the 47th President Entered the White House?</a>
Why It Matters: The reorganization comes as AMD&#8217;s client segment shows strong momentum, posting record revenue of $2.3 billion in the fourth quarter, <a href="https://www.benzinga.com/news/earnings/25/02/43480688/amd-q4-earnings-revenue-beat-eps-beat-data-center-continued-growth">up 58% year-over-year</a>. 
For the first quarter of 2025, AMD expects overall revenue of approximately $7.1 billion, representing 30% year-over-year growth, driven by strength in data center and client businesses offsetting continued <a href="https://www.benzinga.com/news/earnings/25/02/43480688/amd-q4-earnings-revenue-beat-eps-beat-data-center-continued-growth">weakness in gaming and embedded segments</a>.
AMD has a <a href="https://www.benzinga.com/quote/AMD/analyst-ratings">consensus price target</a> of $175.31 from 31 analysts, with a high of $250 and a low of $110. Recent ratings from Morgan Stanley, Rosenblatt, and Susquehanna give an average target of $187.33, implying a 71.96% upside.
Price Action: AMD closed at $119.50 on Tuesday, up 4.58%. After hours, it fell 8.84% to $108.94, down 31.41% over the past year, according to <a href="https://pro.benzinga.com/dashboard">data from Benzinga Pro</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/02/43487682/palantir-ceo-hails-elon-musks-doge-initiative-anticipates-positive-outcome">Alex Karp Says Elon Musk&#8217;s DOGE Initiative Will Be &#8216;Very Good&#8217; For Palantir: &#8216;Expecting To See Really Unexpected Things And To Win&#8217;</a></li>
</ul>
Image Via Shutterstock
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

AMD Merges Client, Gaming Segments After 59% Drop In Gaming Revenue, Aims To Align Reporting With Business Focus

TWLO

Twilio Announced A Multi-year Partnership With Chelsea Football Club, With Twilio Serving As An Official Supplier For The Club

Eurozone Services Purchasing Managers Index For January 51.3 Vs. 51.4 Est.; 51.6 Prior

HCOB Eurozone Composite Purchasing Managers Index For January 50.2 Vs. 50.2 Est.; 49.6 Prior

Germany Services Purchasing Managers Index For January 52.5 Vs. 52.5 Est.; 51.2 Prior

With an estimated 285 million people worldwide suffering from diabetes, the disease has become an epidemic and the problem continues to grow at a startling rate. As the second leading cause of death in the United States, more than 26 million U.S. residents have been diagnosed with diabetes. Advances in effective management are more necessary than ever before. Luckily, an innovative company called PositiveID Corporation (OTCBB: <a href="http://app.quotemedia.com/quotetools/clientForward?targetURL=http://www.smallcapvoice.com/Small-Cap-Stock-Quotes.html&action=showDetailedQuote&symbol=PSID">PSID</a>) is developing three new products that could drastically improve the world of diabetes management.
EasyCheck™, a hand-held device, checks glucose levels in exhaled breath, thus making the traditional finger-pricking method unnecessary. A second product, cleverly called iglucose™, communicates wirelessly with a diabetic's glucometer, automatically downloading glucose data to a central location for further analysis. Finally, GlucoChip™ uses RFID technology combined with a tiny embedded bio-sensor system to measure glucose levels in the body in real-time, making it easier than ever to manage your health.

These unique devices, designed specifically to advance diabetes management, stand to make a significant impact on the medical industry, revolutionizing diabetes care and treatment for patients, doctors, nurses, health care providers, as well as the families of diabetics.
The Diabetes Problem In 2010, the World Health Organization estimated 285 million people worldwide had diabetes, or 6.4% of the global adult population. Experts project the number of people suffering from diabetes will double from 2005 to 2030 bringing the worldwide total to 438 million people or 7.8% of the adult population. Clearly an epidemic, Type 2 diabetes has increased in frequency among children. In 2011, the American Diabetes Association estimated about 1 in every 400 children and adolescents under 20 years of age has diabetes.
Diabetes Kills Diabetes is the second leading cause of death is the United States, as well as the leading cause of kidney failure, non-traumatic lower-limb amputations, and new cases of blindness. Diabetes is also a major cause of heart disease and stroke, according to the Centers for Disease Control and Prevention (<a class="ticker" href="/stock/cdc#">CDC</a>). Likely the world's biggest health challenge in the twenty-first century, diabetes is quickly overtaking the world.
Current Diabetes Management In order to achieve blood glycemic control, a patient must have the ability to effectively monitor their glucose levels. However, this remains difficult and painful for many people. Currently, checking glucose levels involves pricking the finger to access a drop of blood. This process can be so daunting for patients that it is the primary cause for poor compliance with treatments and ineffective disease management.
Check Glucose Levels Using Exhaled Breath EasyCheck, a product currently under development by PositiveID Corporation, tests glucose levels in people with diabetes simply by analyzing the breath exhaled by the patient. The small hand-held device actually checks for increased levels of acetone which directly correlate to glucose in the blood. Using advanced microprocessor and laser technology, EasyCheck has built-in self-calibrating capabilities which ensure accuracy.
Once EasyCheck hits the market, it will be the world's first and only entirely non-invasive glucose tester that provides precise data in a portable device. People with diabetes may finally experience a true breakthrough in glucose management, minimizing difficulty and reducing pain, ultimately encouraging frequent monitoring.
Manage Glucose Data Wirelessly In addition to developing EasyCheck, PositiveID has also developed iglucose™, an FDA-cleared wireless, seamless device designed to connect to a glucometer and send blood glucose data to a central database where the data is used for better diabetes management. To make life a little easier, iglucose is compatible with data-capable glucometers, providing the patient with flexibility to continue to use their preferred glucometer brand.
PositiveID Corporation recently completed Phase II of their GlucoChip development program, focused on perfecting the glucose sensing system, the critical piece of the implantable GlucoChip device. This new closed-cycle system successfully responds to the body's glucose levels and provides consistent, measurable results. In other words, the glucose-sensing system works.
Monitor Glucose Levels in Real-Time Like a gadget from a futuristic movie, GlucoChip will utilize an RFID chip and tiny embedded bio-sensor to measure glucose levels in the body in real-time. Users will be able to read their glucose levels from an external scanner, can use the easy-to-use interface which interacts with the tiny embedded bio-sensor, making it easier than ever to manage your health.
The Rising Cost of Diabetes Living with diabetes also means living with considerably higher health care costs. Because the prevalence of diabetes keeps climbing, the costs skyrockets. For example, in the United States, health care for diabetics costs roughly 2.3 times higher than for non-diabetic patients. The total costs of diagnosed diabetes in the United States, was $174 billion in 2007, according the American Diabetes Association, which has even gone so far as to create a Diabetes Cost Calculator that takes data from national diabetes costs and gives estimates at the state and congressional district level. Factor in the additional cost of undiagnosed diabetes and the total cost of diabetes in the Unites States in 2007 skyrocketed to $218 billion.
With a growing diabetes pandemic, health care providers will quickly become overloaded and patients will be encouraged both verbally and financially to engage in more self-management, which has shown to be more beneficial anyway. As these new products begin to hit the market, expect growing buzz surrounding these new life-changing products, as they will be very popular in the diabetic community.
<hr />
About SmallCapVoice.com
SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients' financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the penny stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in small cap stocks and micro cap stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visit <a href="http://www.smallcapvoice.com/services.html">http://www.smallcapvoice.com/services.html</a>.
IMPORTANT DISCLAIMER – PLEASE READ THOROUGHLY SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. <a href="http://www.smallcapvoice.com/disclaimer.html">Link to full disclosure</a> about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications.
<a href="http://bit.ly/cmaP60" target="_blank">About Penny Stocks</a>
Contact:
Stuart T. Smith CEO 512-267-2430 <a href="mailto:ssmith@smallcapvoice.com">ssmith@smallcapvoice.com</a> <a href="http://www.smallcapvoice.com">http://www.smallcapvoice.com</a>

ICF International (NASDAQ: <a class="ticker" href="/stock/icfi#NASDAQ">ICFI</a>), has won a re-compete contract with the Centers for Disease Control and Prevention (<a class="ticker" href="/stock/cdc#">CDC</a>) to provide data management support and technical assistance to more than 40 CDC-funded grantees. The contract has a value of $9.7 million and a term of one base year and four option years.

Contracts

ICFI

ICF International Awarded $9.7 Million Contract with Centers for Disease Control and Prevention 

Comments

VictoryShares US EQ Income Enhanced Volatility Wtd ETF

News

Latest news for VictoryShares US EQ Income Enhanced Volatility Wtd ETF (NASDAQ:CDC)

Thursday, March 08, 2012

Monday, October 10, 2011

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga